TLR4 signaling in cancer cells promotes chemoattraction of immature dendritic cells via autocrine CCL20

Biochemical and Biophysical Research Communications

Volumn 366, Issue 3, 2008, Pages 852-856

  Wang, Li ^a,b   Liu, Qiuyan ^b   Sun, Qiaoling ^a   Zhang, Chaoxiong ^b   Chen, Taoyong ^b   Cao, Xuetao ^a,b  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

CCL20; Chemoattraction; Chemokine; Colon carcinoma; Dendritic cell; Immune escape; TLR4; Tumor microenvironment

Indexed keywords

MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CANCER CELL; CANCER IMMUNOLOGY; CANCER RESISTANCE; CHRONICITY; COLON CANCER; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; AUTOCRINE COMMUNICATION; CELL COMMUNICATION; CELL LINE, TUMOR; CHEMOKINE CCL20; CHEMOTACTIC FACTORS; COLONIC NEOPLASMS; DENDRITIC CELLS; MICE; TOLL-LIKE RECEPTOR 4;

EID: 37549002935     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.12.030     Document Type: Article

References (27)

1. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
2. Itzkowitz S.H., and Yio X. Inflammation and cancer. IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 287 (2004) 7-17
3. Seril D.N., Lia J., Yang G.Y., and Yang C.S. Oxidative stress and ulcerative colitisassociated carcinogenesis: studies in humans and animal models. Carcinogenesis 24 (2003) 353-362
4. Eaden J., Abrams K., Ekbom A., Jackson E., and Mayberry J. Colorectal cancer prevention in ulcerative colitis: a case control study. Aliment Pharmacol. Ther. 14 (2000) 145-153
5. Akira S., and akeda K. Toll-like receptor signalling. Nat. Immunol. 4 (2004) 499-4511
6. Bohnhorst J., Rasmussen T., Moen S.H., Flottum M., Knudsen L., Borset M., Espevik T., and Sundan A. Toll-like receptors mediate proliferation and survival of multiple myeloma cells. Leukemia 20 (2006) 1138-1144
7. Huang B., Zhao J., Li H., He K.L., Chen Y., Chen S.H., Mayer L., Unkeless J.C., and Xiong H. Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res. 65 (2005) 5009-5014
8. Kelly M.G., Alvero A.B., Chen R., Silasi D.A., Abrahams V.M., Chan S., Visintin I., Rutherford T., and Mor G. TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res. 66 (2006) 3859-3868
9. He W., Liu Q., Wang L., Chen W., Li N., and Cao X. TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Mol. Immunol. 44 (2007) 2850-2859
10. Rabinovich G.A., Gabrilovich D., and Sotomayor E.M. Immunosuppressive strategies that are mediated by tumor cells. Annu. Rev. Immunol. 25 (2007) 267-296
11. Rollins B.J. Inflammatory chemokines in cancer growth and progression. Eur. J. Cancer 42 (2006) 760-767
12. Kimsey T.F., Campbell A.S., Albo D., Wilson M., and Wang T.N. Co-localization of macrophage inflammatory protein-3alpha (Mip-3alpha) and its receptor, CCR6, promotes pancreatic cancer cell invasion. Cancer J. 10 (2004) 374-380
13. Campbell A.S., Albo D., Kimsey T.F., White S.L., and Wang T.N. Macrophage inflammatory protein-3alpha promotes pancreatic cancer cell invasion. J. Surg. Res. 123 (2005) 96-101
14. Bonnotte B., Crittenden M., Larmonier N., Gough M., and Vile R.G. MIP-3alpha transfection into a rodent tumor cell line increases intratumoral dendritic cell infiltration but enhances (facilitates) tumor growth and decreases immunogenicity. J. Immunol. 173 (2004) 4929-4935
15. Blanchard P.D., Freymond N., Isaac S., Guibert B., Pachéco Y., and Lebecque S. Dendritic cells infiltrating human non-small cell lung cancer are blocked at immature stag. J. Immunol. 178 (2007) 2763-2769
16. Liu Q., Chen T., Chen G., Shu X., Sun A., Ma P., Lu L., and Cao X. Triptolide impairs dendritic cell migration by inhibiting CCR7 and COX-2 expression through PI3-K/Akt and NF-κB pathways. Mol. Immunol. 44 (2007) 2686-2696
17. An H., Xu H., Zhang M., Zhou J., Feng T., Qian C., Qi R., and Cao X. Src homology domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through phosphatase activity- and PI-3K-independent mechanism. Blood 105 (2005) 4685-4692
18. Dunn G.P., Old L.J., and Schreiber R.D. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 21 (2004) 137-148
19. Dieu M.C., Vanbervliet B., Vicari A., Bridon J.M., Oldham E., Aït-Yahia S., Brière F., Zlotnik A., Lebecque S., and Caux C. Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J. Exp. Med. 188 (1998) 373-386
20. Wang J.H., Manning B.J., Wu Q.D., Blankson S., Bouchier-Hayes D., and Redmond H.P. Endotoxin/Lipopolysaccharide activates NF-κB and enhances tumor cell adhesion and invasion through a β1 integrin-dependent mechanism. J. Immunol. 170 (2003) 795-804
21. Tichomirowa M., Theodoropoulou M., Lohrer P., Schaaf L., Losa M., Uhl E., Lange M., Arzt E., Stalla G.K., and Renner U. Bacterial endotoxin (Lipopolysaccharide) stimulates interleukin-6 production and inhibits growth of pituitary tumour cells expressing the Toll-Like receptor 4. J. Neuroendocrinol. 17 (2005) 152-160
22. Rollins C.B.J. CCL2 (monocyte chemoattractant protein-1) and cancer. Semin. Cancer Biol. 14 (2004) 149-154
23. Locati M., Deuschle U., Massardi M.L., Martinez F.O., Sironi M., Sozzani S., Bartfai T., and Mantovani A. Analysis of the gene expression profile activated by the CC chemokine ligand 5/RANTES and by lipopolysaccharide in human monocytes. J. Immunol. 168 (2002) 3557-3562
24. Zhang Q., Xiong J., Jin Y., Ju W., Liu C., Wang J., Wu Q., Liu Y., Hu C., Yang M., Gao Q., Zhang K., Sun Z., Li Q., Liu J., and Tan J. CC chemokine ligand 25 enhances resistance to apoptosis in CD4+ T cells from patients with T-cell lineage acute and chronic lymphocytic leukemia by means of livin activation. Cancer Res. 64 (2004) 7579-7587
25. Chaux P., Favre N., Martin M., and Martin F. Tumor-infiltrating dendritic cells are defective in their antigen-presenting function and inducible B7 expression in rats. Int. J. Cancer 72 (1997) 619-624
26. Enk H., Jonuleit H., Saloga J., and Knop J. Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma. Int. J. Cancer 73 (1997) 309-316
27. Bonifaz L., Bonnyay D., Mahnke K., Rivera M., Nussenzweig M.C., and Steinman R.M. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J. Exp. Med. 196 (2002) 1627-1638